Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vasopressin receptor V1A (AVPR1A) is a G protein-coupled receptor that binds arginine vasopressin. It mediates vasoconstriction, modulates social behaviors, and is involved in platelet aggregation. It is a therapeutic target for conditions involving abnormal social behavior, stress responses, and cardiovascular diseases.
Antagonism of V1A receptor to reduce vasoconstriction or modulate social behavior.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vasopressin Receptor V1A (V1A).